Contact us

1. Please pick the category below that best describes you:

2. Which of the following best describes your inquiry?

Submit your inquiry

If you have additional questions, please fill out the form below:

    I agree that Adaptive Biotechnologies can contact me with information about immunoSEQ Technology and Products. You will have the option to unsubscribe at any time.


    Adaptive considers research projects that align with the company’s strategic development goals on a case-by-case basis. Currently, we are prioritizing projects in autoimmune and infectious disease research. If you are interested in a research collaboration, please submit an application. For questions, please contact

    • Research proposals can focus on any aspect of immunology
    • Proposals must be one page in length and can be designed using any immunoSEQ® Assay


    Criteria for Evaluation

    Some of the factors proposals will be evaluated on are:

    • The innovative use of immunoSEQ Assays in the research concept
    • The soundness of research design
    • The value of the research to the field of immunology
    • Large sample sets or patient groups
    • Retrospective studies with samples already collected
    • Adequate samples available. Please review Sample Guidelines.


    Terms of Collaboration

    Applicants selected as collaborators will be required to sign an agreement with the following terms:

    • Co-ownership of the immunosequencing data and metadata
    • Co-analysis of data including relevant metadata (i.e. outcomes)
    • Co-authorship on any manuscripts published using the immunosequencing data
    • Applicant’s rights to submit the samples and metadata for analysis
    • Submission of data by both parties for oral presentations or poster presentations at scientific meetings
    • Inclusion of all de-identified data and metadata in immuneACCESS®, Adaptive’s public sequence database post-publication


    How to apply

    To apply for a collaboration, complete the information requested below. Please understand that if your project is not selected, Adaptive is not making a judgement related to the scientific merit of your project. Rather, the Company is allocating its R&D budget in predefined strategic objectives. Additionally, please note that data from collaborations will be shared with Adaptive and is subject to contribution to a public database after an agreed upon period of time set aside for publication.

    If you have additional questions, please fill out the Medical Information request form below:

      Covid Icon Covid Icon
      COVID-19 Applications

      Learn how immunoSEQ® T-MAP™ COVID can help uncover the T-cell immune response in COVID-19.

      Learn More
      Library Icon Email Icon

      Access technical documents for getting started with the immunoSEQ® Service product, grant writing support, and FAQs.

      Learn More